Global RNA Interference (RNAi) Drug Delivery Market Outlook 2021

Global RNA Interference (RNAi) Drug Delivery Market Outlook 2021

Table of Contents
1 RNA Interference (RNAi) Drug Delivery Market Overview
1.1 Product Overview and Scope of RNA Interference (RNAi) Drug Delivery
1.2 RNA Interference (RNAi) Drug Delivery Segment by Type
1.2.1 Global RNA Interference (RNAi) Drug Delivery Production Growth Rate Comparison by Type 2020 VS 2026
1.2.2 Nanoparticle Drug Delivery Technology
1.2.3 Pulmonary Drug Delivery Technology
1.2.4 Nucleic Acid Drug Delivery Technology
1.2.5 Aptamer Drug Delivery Technology
1.3 RNA Interference (RNAi) Drug Delivery Segment by Application
1.3.1 RNA Interference (RNAi) Drug Delivery Consumption Comparison by Application: 2020 VS 2026
1.3.2 Infectious Diseases
1.3.3 Cardiology
1.3.4 Oncology
1.3.5 Neurology
1.3.6 Ophthalmology
1.3.7 Metabolic Disorders
1.4 Global RNA Interference (RNAi) Drug Delivery Market by Region
1.4.1 Global RNA Interference (RNAi) Drug Delivery Market Size Estimates and Forecasts by Region: 2020 VS 2026
1.4.2 North America Estimates and Forecasts (2015-2026)
1.4.3 Europe Estimates and Forecasts (2015-2026)
1.4.4 China Estimates and Forecasts (2015-2026)
1.4.5 Japan Estimates and Forecasts (2015-2026)
1.5 Global RNA Interference (RNAi) Drug Delivery Growth Prospects
1.5.1 Global RNA Interference (RNAi) Drug Delivery Revenue Estimates and Forecasts (2015-2026)
1.5.2 Global RNA Interference (RNAi) Drug Delivery Production Capacity Estimates and Forecasts (2015-2026)
1.5.3 Global RNA Interference (RNAi) Drug Delivery Production Estimates and Forecasts (2015-2026)
1.6 RNA Interference (RNAi) Drug Delivery Industry
1.7 RNA Interference (RNAi) Drug Delivery Market Trends
2 Market Competition by Manufacturers
2.1 Global RNA Interference (RNAi) Drug Delivery Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global RNA Interference (RNAi) Drug Delivery Revenue Share by Manufacturers (2015-2020)
2.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.4 Global RNA Interference (RNAi) Drug Delivery Average Price by Manufacturers (2015-2020)
2.5 Manufacturers RNA Interference (RNAi) Drug Delivery Production Sites, Area Served, Product Types
2.6 RNA Interference (RNAi) Drug Delivery Market Competitive Situation and Trends
2.6.1 RNA Interference (RNAi) Drug Delivery Market Concentration Rate
2.6.2 Global Top 3 and Top 5 Players Market Share by Revenue
2.6.3 Mergers & Acquisitions, Expansion
3 Production and Capacity by Region
3.1 Global Production Capacity of RNA Interference (RNAi) Drug Delivery Market Share by Regions (2015-2020)
3.2 Global RNA Interference (RNAi) Drug Delivery Revenue Market Share by Regions (2015-2020)
3.3 Global RNA Interference (RNAi) Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 North America RNA Interference (RNAi) Drug Delivery Production
3.4.1 North America RNA Interference (RNAi) Drug Delivery Production Growth Rate (2015-2020)
3.4.2 North America RNA Interference (RNAi) Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe RNA Interference (RNAi) Drug Delivery Production
3.5.1 Europe RNA Interference (RNAi) Drug Delivery Production Growth Rate (2015-2020)
3.5.2 Europe RNA Interference (RNAi) Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 China RNA Interference (RNAi) Drug Delivery Production
3.6.1 China RNA Interference (RNAi) Drug Delivery Production Growth Rate (2015-2020)
3.6.2 China RNA Interference (RNAi) Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Japan RNA Interference (RNAi) Drug Delivery Production
3.7.1 Japan RNA Interference (RNAi) Drug Delivery Production Growth Rate (2015-2020)
3.7.2 Japan RNA Interference (RNAi) Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)
4 Global RNA Interference (RNAi) Drug Delivery Consumption by Regions
4.1 Global RNA Interference (RNAi) Drug Delivery Consumption by Regions
4.1.1 Global RNA Interference (RNAi) Drug Delivery Consumption by Region
4.1.2 Global RNA Interference (RNAi) Drug Delivery Consumption Market Share by Region
4.2 North America
4.2.1 North America RNA Interference (RNAi) Drug Delivery Consumption by Countries
4.2.2 U.S.
4.2.3 Canada
4.3 Europe
4.3.1 Europe RNA Interference (RNAi) Drug Delivery Consumption by Countries
4.3.2 Germany
4.3.3 France
4.3.4 U.K.
4.3.5 Italy
4.3.6 Russia
4.4 Asia Pacific
4.4.1 Asia Pacific RNA Interference (RNAi) Drug Delivery Consumption by Region
4.4.2 China
4.4.3 Japan
4.4.4 South Korea
4.4.5 Taiwan
4.4.6 Southeast Asia
4.4.7 India
4.4.8 Australia
4.5 Latin America
4.5.1 Latin America RNA Interference (RNAi) Drug Delivery Consumption by Countries
4.5.2 Mexico
4.5.3 Brazil
5 RNA Interference (RNAi) Drug Delivery Production, Revenue, Price Trend by Type
5.1 Global RNA Interference (RNAi) Drug Delivery Production Market Share by Type (2015-2020)
5.2 Global RNA Interference (RNAi) Drug Delivery Revenue Market Share by Type (2015-2020)
5.3 Global RNA Interference (RNAi) Drug Delivery Price by Type (2015-2020)
5.4 Global RNA Interference (RNAi) Drug Delivery Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
6 Global RNA Interference (RNAi) Drug Delivery Market Analysis by Application
6.1 Global RNA Interference (RNAi) Drug Delivery Consumption Market Share by Application (2015-2020)
6.2 Global RNA Interference (RNAi) Drug Delivery Consumption Growth Rate by Application (2015-2020)
7 Company Profiles and Key Figures in RNA Interference (RNAi) Drug Delivery Business
7.1 Metabolic disorders
7.1.1 Metabolic disorders RNA Interference (RNAi) Drug Delivery Production Sites and Area Served
7.1.2 Metabolic disorders RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification
7.1.3 Metabolic disorders RNA Interference (RNAi) Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.1.4 Metabolic disorders Main Business and Markets Served
7.2 Alnylam Pharmaceuticals Inc
7.2.1 Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Production Sites and Area Served
7.2.2 Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification
7.2.3 Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.2.4 Alnylam Pharmaceuticals Inc Main Business and Markets Served
7.3 Merck & Co. Inc
7.3.1 Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Production Sites and Area Served
7.3.2 Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification
7.3.3 Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.3.4 Merck & Co. Inc Main Business and Markets Served
7.4 Access Pharmaceuticals Inc
7.4.1 Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Production Sites and Area Served
7.4.2 Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification
7.4.3 Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.4.4 Access Pharmaceuticals Inc Main Business and Markets Served
7.5 Dicerna Pharmaceuticals Inc
7.5.1 Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Production Sites and Area Served
7.5.2 Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification
7.5.3 Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.5.4 Dicerna Pharmaceuticals Inc Main Business and Markets Served
7.6 Calondo Pharmaceuticals Inc
7.6.1 Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Production Sites and Area Served
7.6.2 Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification
7.6.3 Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.6.4 Calondo Pharmaceuticals Inc Main Business and Markets Served
7.7 Marina Biotech Inc
7.7.1 Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Production Sites and Area Served
7.7.2 Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification
7.7.3 Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.7.4 Marina Biotech Inc Main Business and Markets Served
7.8 RXi Pharmaceuticals Corp
7.8.1 RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Production Sites and Area Served
7.8.2 RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification
7.8.3 RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.8.4 RXi Pharmaceuticals Corp Main Business and Markets Served
7.9 Quark Pharmaceuticals Inc
7.9.1 Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Production Sites and Area Served
7.9.2 Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification
7.9.3 Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.9.4 Quark Pharmaceuticals Inc Main Business and Markets Served
7.10 Silence Therapeutics plc
7.10.1 Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Production Sites and Area Served
7.10.2 Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification
7.10.3 Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.10.4 Silence Therapeutics plc Main Business and Markets Served
7.11 Tacere Therapeutics Inc
7.11.1 Tacere Therapeutics Inc RNA Interference (RNAi) Drug Delivery Production Sites and Area Served
7.11.2 Tacere Therapeutics Inc RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification
7.11.3 Tacere Therapeutics Inc RNA Interference (RNAi) Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.11.4 Tacere Therapeutics Inc Main Business and Markets Served
7.12 PhaseRx Inc
7.12.1 PhaseRx Inc RNA Interference (RNAi) Drug Delivery Production Sites and Area Served
7.12.2 PhaseRx Inc RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification
7.12.3 PhaseRx Inc RNA Interference (RNAi) Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.12.4 PhaseRx Inc Main Business and Markets Served
7.13 Sirnaomics Inc
7.13.1 Sirnaomics Inc RNA Interference (RNAi) Drug Delivery Production Sites and Area Served
7.13.2 Sirnaomics Inc RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification
7.13.3 Sirnaomics Inc RNA Interference (RNAi) Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.13.4 Sirnaomics Inc Main Business and Markets Served
7.14 Traversa Therapeutics Inc
7.14.1 Traversa Therapeutics Inc RNA Interference (RNAi) Drug Delivery Production Sites and Area Served
7.14.2 Traversa Therapeutics Inc RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification
7.14.3 Traversa Therapeutics Inc RNA Interference (RNAi) Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.14.4 Traversa Therapeutics Inc Main Business and Markets Served
8 RNA Interference (RNAi) Drug Delivery Manufacturing Cost Analysis
8.1 RNA Interference (RNAi) Drug Delivery Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Raw Materials Price Trend
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of RNA Interference (RNAi) Drug Delivery
8.4 RNA Interference (RNAi) Drug Delivery Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 RNA Interference (RNAi) Drug Delivery Distributors List
9.3 RNA Interference (RNAi) Drug Delivery Customers
10 Market Dynamics
10.1 Market Trends
10.2 Opportunities and Drivers
10.3 Challenges
10.4 Porter's Five Forces Analysis
11 Production and Supply Forecast
11.1 Global Forecasted Production of RNA Interference (RNAi) Drug Delivery (2021-2026)
11.2 Global Forecasted Revenue of RNA Interference (RNAi) Drug Delivery (2021-2026)
11.3 Global Forecasted Price of RNA Interference (RNAi) Drug Delivery (2021-2026)
11.4 Global RNA Interference (RNAi) Drug Delivery Production Forecast by Regions (2021-2026)
11.4.1 North America RNA Interference (RNAi) Drug Delivery Production, Revenue Forecast (2021-2026)
11.4.2 Europe RNA Interference (RNAi) Drug Delivery Production, Revenue Forecast (2021-2026)
11.4.3 China RNA Interference (RNAi) Drug Delivery Production, Revenue Forecast (2021-2026)
11.4.4 Japan RNA Interference (RNAi) Drug Delivery Production, Revenue Forecast (2021-2026)
12 Consumption and Demand Forecast
12.1 Global Forecasted and Consumption Demand Analysis of RNA Interference (RNAi) Drug Delivery
12.2 North America Forecasted Consumption of RNA Interference (RNAi) Drug Delivery by Country
12.3 Europe Market Forecasted Consumption of RNA Interference (RNAi) Drug Delivery by Country
12.4 Asia Pacific Market Forecasted Consumption of RNA Interference (RNAi) Drug Delivery by Regions
12.5 Latin America Forecasted Consumption of RNA Interference (RNAi) Drug Delivery
13 Forecast by Type and by Application (2021-2026)
13.1 Global Production, Revenue and Price Forecast by Type (2021-2026)
13.1.1 Global Forecasted Production of RNA Interference (RNAi) Drug Delivery by Type (2021-2026)
13.1.2 Global Forecasted Revenue of RNA Interference (RNAi) Drug Delivery by Type (2021-2026)
13.1.3 Global Forecasted Price of RNA Interference (RNAi) Drug Delivery by Type (2021-2026)
13.2 Global Forecasted Consumption of RNA Interference (RNAi) Drug Delivery by Application (2021-2026)
14 Research Finding and Conclusion
15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer
List of Tables
Table 1. Global RNA Interference (RNAi) Drug Delivery Production (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global RNA Interference (RNAi) Drug Delivery Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 3. Global RNA Interference (RNAi) Drug Delivery Consumption (K Units) Comparison by Application: 2020 VS 2026
Table 4. Global RNA Interference (RNAi) Drug Delivery Production (K Units) by Manufacturers
Table 5. Global RNA Interference (RNAi) Drug Delivery Production (K Units) by Manufacturers (2015-2020)
Table 6. Global RNA Interference (RNAi) Drug Delivery Production Share by Manufacturers (2015-2020)
Table 7. Global RNA Interference (RNAi) Drug Delivery Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global RNA Interference (RNAi) Drug Delivery Revenue Share by Manufacturers (2015-2020)
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNA Interference (RNAi) Drug Delivery as of 2019)
Table 10. Global Market RNA Interference (RNAi) Drug Delivery Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 11. Manufacturers RNA Interference (RNAi) Drug Delivery Production Sites and Area Served
Table 12. Manufacturers RNA Interference (RNAi) Drug Delivery Product Types
Table 13. Global RNA Interference (RNAi) Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global RNA Interference (RNAi) Drug Delivery Capacity (K Units) by Region (2015-2020)
Table 16. Global RNA Interference (RNAi) Drug Delivery Production (K Units) by Region (2015-2020)
Table 17. Global RNA Interference (RNAi) Drug Delivery Revenue (Million US$) by Region (2015-2020)
Table 18. Global RNA Interference (RNAi) Drug Delivery Revenue Market Share by Region (2015-2020)
Table 19. Global RNA Interference (RNAi) Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 20. North America RNA Interference (RNAi) Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 21. Europe RNA Interference (RNAi) Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 22. China RNA Interference (RNAi) Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 23. Japan RNA Interference (RNAi) Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 24. Global RNA Interference (RNAi) Drug Delivery Consumption (K Units) Market by Region (2015-2020)
Table 25. Global RNA Interference (RNAi) Drug Delivery Consumption Market Share by Region (2015-2020)
Table 26. North America RNA Interference (RNAi) Drug Delivery Consumption by Countries (2015-2020) (K Units)
Table 27. Europe RNA Interference (RNAi) Drug Delivery Consumption by Countries (2015-2020) (K Units)
Table 28. Asia Pacific RNA Interference (RNAi) Drug Delivery Consumption by Regions (2015-2020) (K Units)
Table 29. Latin America RNA Interference (RNAi) Drug Delivery Consumption by Countries (2015-2020) (K Units)
Table 30. Global RNA Interference (RNAi) Drug Delivery Production (K Units) by Type (2015-2020)
Table 31. Global RNA Interference (RNAi) Drug Delivery Production Share by Type (2015-2020)
Table 32. Global RNA Interference (RNAi) Drug Delivery Revenue (Million US$) by Type (2015-2020)
Table 33. Global RNA Interference (RNAi) Drug Delivery Revenue Share by Type (2015-2020)
Table 34. Global RNA Interference (RNAi) Drug Delivery Price (USD/Unit) by Type (2015-2020)
Table 35. Global RNA Interference (RNAi) Drug Delivery Consumption (K Units) by Application (2015-2020)
Table 36. Global RNA Interference (RNAi) Drug Delivery Consumption Market Share by Application (2015-2020)
Table 37. Global RNA Interference (RNAi) Drug Delivery Consumption Growth Rate by Application (2015-2020)
Table 38. Metabolic disorders RNA Interference (RNAi) Drug Delivery Production Sites and Area Served
Table 39. Metabolic disorders Specification and Application
Table 40. Metabolic disorders RNA Interference (RNAi) Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 41. Metabolic disorders Main Business and Markets Served
Table 42. Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Production Sites and Area Served
Table 43. Alnylam Pharmaceuticals Inc Specification and Application
Table 44. Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 45. Alnylam Pharmaceuticals Inc Main Business and Markets Served
Table 46. Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Production Sites and Area Served
Table 47. Merck & Co. Inc Specification and Application
Table 48. Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 49. Merck & Co. Inc Main Business and Markets Served
Table 50. Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Production Sites and Area Served
Table 51. Access Pharmaceuticals Inc Specification and Application
Table 52. Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 53. Access Pharmaceuticals Inc Main Business and Markets Served
Table 54. Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Production Sites and Area Served
Table 55. Dicerna Pharmaceuticals Inc Specification and Application
Table 56. Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 57. Dicerna Pharmaceuticals Inc Main Business and Markets Served
Table 58. Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Production Sites and Area Served
Table 59. Calondo Pharmaceuticals Inc Specification and Application
Table 60. Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Calondo Pharmaceuticals Inc Main Business and Markets Served
Table 62. Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Production Sites and Area Served
Table 63. Marina Biotech Inc Specification and Application
Table 64. Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 65. Marina Biotech Inc Main Business and Markets Served
Table 66. RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Production Sites and Area Served
Table 67. RXi Pharmaceuticals Corp Specification and Application
Table 68. RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 69. RXi Pharmaceuticals Corp Main Business and Markets Served
Table 70. Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Production Sites and Area Served
Table 71. Quark Pharmaceuticals Inc Specification and Application
Table 72. Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Quark Pharmaceuticals Inc Main Business and Markets Served
Table 74. Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Production Sites and Area Served
Table 75. Silence Therapeutics plc Specification and Application
Table 76. Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Silence Therapeutics plc Main Business and Markets Served
Table 78. Tacere Therapeutics Inc RNA Interference (RNAi) Drug Delivery Production Sites and Area Served
Table 79. Tacere Therapeutics Inc Specification and Application
Table 80. Tacere Therapeutics Inc RNA Interference (RNAi) Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Tacere Therapeutics Inc Main Business and Markets Served
Table 82. PhaseRx Inc RNA Interference (RNAi) Drug Delivery Production Sites and Area Served
Table 83. PhaseRx Inc Specification and Application
Table 84. PhaseRx Inc RNA Interference (RNAi) Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 85. PhaseRx Inc Main Business and Markets Served
Table 86. Sirnaomics Inc RNA Interference (RNAi) Drug Delivery Production Sites and Area Served
Table 87. Sirnaomics Inc Specification and Application
Table 88. Sirnaomics Inc RNA Interference (RNAi) Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Sirnaomics Inc Main Business and Markets Served
Table 90. Traversa Therapeutics Inc RNA Interference (RNAi) Drug Delivery Production Sites and Area Served
Table 91. Traversa Therapeutics Inc Specification and Application
Table 92. Traversa Therapeutics Inc RNA Interference (RNAi) Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Traversa Therapeutics Inc Main Business and Markets Served
Table 94. Production Base and Market Concentration Rate of Raw Material
Table 95. Key Suppliers of Raw Materials
Table 96. RNA Interference (RNAi) Drug Delivery Distributors List
Table 97. RNA Interference (RNAi) Drug Delivery Customers List
Table 98. RNA Interference (RNAi) Drug Delivery Market Trends
Table 99. RNA Interference (RNAi) Drug Delivery Opportunities and Drivers
Table 100. RNA Interference (RNAi) Drug Delivery Market Challenges
Table 101. Global RNA Interference (RNAi) Drug Delivery Production (K Units) Forecast by Region (2021-2026)
Table 102. North America RNA Interference (RNAi) Drug Delivery Consumption Forecast 2021-2026 (K Units) by Country
Table 103. Europe RNA Interference (RNAi) Drug Delivery Consumption Forecast 2021-2026 (K Units) by Country
Table 104. Asia Pacific RNA Interference (RNAi) Drug Delivery Consumption Forecast 2021-2026 (K Units) by Regions
Table 105. Latin America RNA Interference (RNAi) Drug Delivery Consumption Forecast 2021-2026 (K Units) by Country
Table 106. Global RNA Interference (RNAi) Drug Delivery Consumption (K Units) Forecast by Regions (2021-2026)
Table 107. Global RNA Interference (RNAi) Drug Delivery Production (K Units) Forecast by Type (2021-2026)
Table 108. Global RNA Interference (RNAi) Drug Delivery Revenue (Million US$) Forecast by Type (2021-2026)
Table 109. Global RNA Interference (RNAi) Drug Delivery Price (USD/Unit) Forecast by Type (2021-2026)
Table 110. Global RNA Interference (RNAi) Drug Delivery Consumption (K Units) Forecast by Application (2021-2026)
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of RNA Interference (RNAi) Drug Delivery
Figure 2. Global RNA Interference (RNAi) Drug Delivery Production Market Share by Type: 2020 VS 2026
Figure 3. Nanoparticle Drug Delivery Technology Product Picture
Figure 4. Pulmonary Drug Delivery Technology Product Picture
Figure 5. Nucleic Acid Drug Delivery Technology Product Picture
Figure 6. Aptamer Drug Delivery Technology Product Picture
Figure 7. Global RNA Interference (RNAi) Drug Delivery Consumption Market Share by Application: 2020 VS 2026
Figure 8. Infectious Diseases
Figure 9. Cardiology
Figure 10. Oncology
Figure 11. Neurology
Figure 12. Ophthalmology
Figure 13. Metabolic Disorders
Figure 14. North America RNA Interference (RNAi) Drug Delivery Revenue (Million US$) and Growth Rate (2015-2026)
Figure 15. Europe RNA Interference (RNAi) Drug Delivery Revenue (Million US$) and Growth Rate (2015-2026)
Figure 16. China RNA Interference (RNAi) Drug Delivery Revenue (Million US$) and Growth Rate (2015-2026)
Figure 17. Japan RNA Interference (RNAi) Drug Delivery Revenue (Million US$) and Growth Rate (2015-2026)
Figure 18. Global RNA Interference (RNAi) Drug Delivery Revenue (Million US$) (2015-2026)
Figure 19. Global RNA Interference (RNAi) Drug Delivery Production Capacity (K Units) (2015-2026)
Figure 20. RNA Interference (RNAi) Drug Delivery Production Share by Manufacturers in 2019
Figure 21. Global RNA Interference (RNAi) Drug Delivery Revenue Share by Manufacturers in 2019
Figure 22. RNA Interference (RNAi) Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Market RNA Interference (RNAi) Drug Delivery Average Price (USD/Unit) of Key Manufacturers in 2019
Figure 24. The Global 5 and 10 Largest Players: Market Share by RNA Interference (RNAi) Drug Delivery Revenue in 2019
Figure 25. Global RNA Interference (RNAi) Drug Delivery Production Market Share by Region (2015-2020)
Figure 26. Global RNA Interference (RNAi) Drug Delivery Production Market Share by Region in 2019
Figure 27. Global RNA Interference (RNAi) Drug Delivery Revenue Market Share by Region (2015-2020)
Figure 28. Global RNA Interference (RNAi) Drug Delivery Revenue Market Share by Region in 2019
Figure 29. Global RNA Interference (RNAi) Drug Delivery Production (K Units) Growth Rate (2015-2020)
Figure 30. North America RNA Interference (RNAi) Drug Delivery Production (K Units) Growth Rate (2015-2020)
Figure 31. Europe RNA Interference (RNAi) Drug Delivery Production (K Units) Growth Rate (2015-2020)
Figure 32. China RNA Interference (RNAi) Drug Delivery Production (K Units) Growth Rate (2015-2020)
Figure 33. Japan RNA Interference (RNAi) Drug Delivery Production (K Units) Growth Rate (2015-2020)
Figure 34. Global RNA Interference (RNAi) Drug Delivery Consumption Market Share by Region (2015-2020)
Figure 35. Global RNA Interference (RNAi) Drug Delivery Consumption Market Share by Region in 2019
Figure 36. North America RNA Interference (RNAi) Drug Delivery Consumption Growth Rate (2015-2020) (K Units)
Figure 37. North America RNA Interference (RNAi) Drug Delivery Consumption Market Share by Countries in 2019
Figure 38. Canada RNA Interference (RNAi) Drug Delivery Consumption Growth Rate (2015-2020) (K Units)
Figure 39. U.S. RNA Interference (RNAi) Drug Delivery Consumption Growth Rate (2015-2020) (K Units)
Figure 40. Europe RNA Interference (RNAi) Drug Delivery Consumption Growth Rate (2015-2020) (K Units)
Figure 41. Europe RNA Interference (RNAi) Drug Delivery Consumption Market Share by Countries in 2019
Figure 42. Germany America RNA Interference (RNAi) Drug Delivery Consumption Growth Rate (2015-2020) (K Units)
Figure 43. France RNA Interference (RNAi) Drug Delivery Consumption Growth Rate (2015-2020) (K Units)
Figure 44. U.K. RNA Interference (RNAi) Drug Delivery Consumption Growth Rate (2015-2020) (K Units)
Figure 45. Italy RNA Interference (RNAi) Drug Delivery Consumption Growth Rate (2015-2020) (K Units)
Figure 46. Russia RNA Interference (RNAi) Drug Delivery Consumption Growth Rate (2015-2020) (K Units)
Figure 47. Asia Pacific RNA Interference (RNAi) Drug Delivery Consumption Growth Rate (2015-2020) (K Units)
Figure 48. Asia Pacific RNA Interference (RNAi) Drug Delivery Consumption Market Share by Regions in 2019
Figure 49. China RNA Interference (RNAi) Drug Delivery Consumption Growth Rate (2015-2020) (K Units)
Figure 50. Japan RNA Interference (RNAi) Drug Delivery Consumption Growth Rate (2015-2020) (K Units)
Figure 51. South Korea RNA Interference (RNAi) Drug Delivery Consumption Growth Rate (2015-2020) (K Units)
Figure 52. Taiwan RNA Interference (RNAi) Drug Delivery Consumption Growth Rate (2015-2020) (K Units)
Figure 53. Southeast Asia RNA Interference (RNAi) Drug Delivery Consumption Growth Rate (2015-2020) (K Units)
Figure 54. India RNA Interference (RNAi) Drug Delivery Consumption Growth Rate (2015-2020) (K Units)
Figure 55. Australia RNA Interference (RNAi) Drug Delivery Consumption Growth Rate (2015-2020) (K Units)
Figure 56. Latin America RNA Interference (RNAi) Drug Delivery Consumption Growth Rate (2015-2020) (K Units)
Figure 57. Latin America RNA Interference (RNAi) Drug Delivery Consumption Market Share by Countries in 2019
Figure 58. Mexico RNA Interference (RNAi) Drug Delivery Consumption Growth Rate (2015-2020) (K Units)
Figure 59. Brazil RNA Interference (RNAi) Drug Delivery Consumption Growth Rate (2015-2020) (K Units)
Figure 60. Production Market Share of RNA Interference (RNAi) Drug Delivery by Type (2015-2020)
Figure 61. Production Market Share of RNA Interference (RNAi) Drug Delivery by Type in 2019
Figure 62. Revenue Share of RNA Interference (RNAi) Drug Delivery by Type (2015-2020)
Figure 63. Revenue Market Share of RNA Interference (RNAi) Drug Delivery by Type in 2019

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs